BioRestorative Therapies (BRTX) Changes Auditor; Audit Committee Opens Investigation

What Happened BioRestorative Therapies, Inc. (BRTX) filed an amendment to its Form 8‑K on September 10, 2026 announcing a change in its certifying accountant, that the company’s audit committee is performing an investigation, and that the company has engaged Bush & Associates CPA for related services. The amendment updates an earlier Form 8‑K and states no other changes were made to the original filing.

Key Details

• Filing date: September 10, 2026 (Form 8‑K Amendment).
• Change reported: replacement/change in the registrant’s certifying accountant and engagement of Bush & Associates CPA.
• Audit committee: an investigation is being performed by the company’s audit committee (scope described in the amendment).
• Exhibit included: Letter from CBIZ CPAs P.C. to the SEC is filed as Exhibit 16.1.

Why It Matters Changes to the company’s certifying accountant and an active audit‑committee investigation relate directly to the oversight and reliability of the company’s financial reporting. Investors should review this amendment alongside the Original Form 8‑K and monitor future disclosures for results of the investigation, any auditor reports, or impacts on financial statements and filings.